Population pharmacokinetic modeling of PF-06439535 (a bevacizumab biosimilar) and reference bevacizumab (Avastin®) in patients with advanced non-squamous non-small cell lung cancer

被引：0
|
作者：
Cheryl S. W. Li
Kevin Sweeney
Carol Cronenberger
机构：
[1] Pfizer Global Product Development,Clinical Pharmacology/Pharmacometrics
[2] Pfizer Inc.,Clinical Pharmacology/Pharmacometrics
[3] Pfizer Global Product Development,Clinical Pharmacology/Pharmacometrics
[4] Pfizer Inc.,undefined
[5] Pfizer Global Product Development,undefined
[6] Pfizer Inc.,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2020年 / 85卷
关键词：
Bevacizumab; Biosimilar; Non-small cell lung cancer; PF-06439535; Population pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：487 / 499
页数：12
相关论文
共 50 条
  • [21] Clinical efficacy of bevacizumab combined with chemotherapy in the treatment of advanced non-squamous non-small cell lung cancer
    Liu, Yuhua
    Mao, Aihong
    Ma, Qin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (07): : 9049 - 9057
  • [22] A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer
    Yoshida, Hironori
    Kim, Young Hak
    Sakamori, Yuichi
    Nagai, Hiroki
    Ozasa, Hiroaki
    Kaneda, Toshihiko
    Yoshioka, Hiroshige
    Nakagawa, Hiroaki
    Tomii, Keisuke
    Okada, Asuka
    Yoshimura, Kenichi
    Hirabayashi, Masataka
    Hirai, Toyohiro
    ANTICANCER RESEARCH, 2020, 40 (05) : 2981 - 2987
  • [23] ADVERSE EFFECTS IN COMBINATION THERAPY WITH BEVACIZUMAB IN ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER - RETROSPECTIVE STUDY
    Cerna, Maria
    Berzinec, Peter
    Kasan, Peter
    Chowaniecova, Gabriela
    Martak, Marian
    Vesela, Milada
    Jancokova, Iveta
    Kuliskova, Iveta
    Mazal, Juraj
    Kavcova, Elena
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1199 - S1199
  • [24] A phase II study of oxaliplatin and pemetrexed plus bevacizumab in advanced non-squamous non-small cell lung cancer
    Waples, J. M.
    Auerbach, M.
    Boccia, R.
    Wiggans, R. G.
    Steis, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Bevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis.
    Trukhin, Dmytro
    Poddubskaya, Elena
    Zoran, Andric
    Bondarenko, Igor
    Shevnia, Serhii
    Zaric, Bojan
    Bellala, Ravishankar
    Charoentum, Chaiyut
    Perez, Luis
    Bullo, Felicitas
    Garcia, Fernanda
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [26] Efficacy and Safety of Biosimilar QL1101 Compared with Avastin in Patients with Non-Squamous Non-Small Cell Lung Cancer
    Han, B.
    Li, K.
    Chu, T.
    Bi, M.
    Zhang, H.
    Yu, Y.
    Shi, J.
    Zhang, X.
    Chen, Z.
    Han, C.
    Bai, T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S355 - S355
  • [27] Pemetrexed and carboplatin plus bevacizumab for advanced non-squamous non-small cell lung cancer (NSCLC): Preliminary results
    Patel, J. D.
    Hensing, T. A.
    Villafor, V.
    Hart, E.
    Bonomi, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] Enhanced FGFR signaling correlates with erlotinib/bevacizumab response in advanced non-squamous non-small cell lung cancer
    Franzini, Anca
    Baty, Florent
    Brutsche, Martin
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [29] Cost-efficiency and expanded access modeling of conversion to biosimilar bevacizumab in metastatic colorectal and non-squamous non-small cell lung cancer in Medicare
    Roth, Joshua A.
    Kratochvil, David
    Dorman, Stephanie
    Bernauer, Mark
    JOURNAL OF MEDICAL ECONOMICS, 2025, 28 (01) : 378 - 386
  • [30] Pilot phase II study of metronomic chemotherapy in combination with bevacizumab in patients with advanced non-squamous non-small cell lung cancer
    Jones, Benjamin S.
    Jerome, Mary S.
    Miley, Deborah
    Jackson, Bradford E.
    DeShazo, Mollie R.
    Reddy, Vishnu V. B.
    Singh, Karan P.
    Brown, Olivia C.
    Robert, Francisco
    LUNG CANCER, 2017, 106 : 125 - 130
12345